扩大药师处方权限对COVID-19疫苗接种率的影响

Innovations in pharmacy Pub Date : 2025-04-23 eCollection Date: 2025-01-01 DOI:10.24926/iip.v16i1.6126
Taylor Le, Thomas Kelly
{"title":"扩大药师处方权限对COVID-19疫苗接种率的影响","authors":"Taylor Le, Thomas Kelly","doi":"10.24926/iip.v16i1.6126","DOIUrl":null,"url":null,"abstract":"<p><p><i>Background</i>: Recent legislatures have granted expanded prescriptive authority to pharmacists with a collaborative practice agreement with a physician. This authority could include prescribing tobacco cessation products, birth controls, and antivirals for COVID-19. Although closely associated with providing preventative measures for COVID-19 in the forms of testing and vaccinations, the relationship between pharmacist prescriptive power and rate of COVID-19 vaccination remains unexplored. The objective of the study is to determine the association between pharmacist prescriptive authority and the rate of COVID-19 vaccinations between neighboring counties along state lines of states with differing laws on this prescriptive power. <i>Methods</i>: States with expanded pharmacist prescriptive authority include: New Mexico, Oregon, Idaho, Florida, California, North Carolina, Montana, New York, Iowa, Massachusetts, and Ohio. Counties are selected if the center of the county is within 30 miles from a state border that divides a state with expanded pharmacist prescriptive authority from a state without. Monthly vaccination data from January 2021 to December 2021 was acquired from the Centers for Disease Control and Prevention and linear regression was performed and state-border-pair fixed effects was used as a control. <i>Results</i>: The estimated effect of expanded prescriptive authority is an increase of five percentage points in the share of the adult population that completed the initial COVID-19 vaccine series. <i>Conclusion</i>: The relationship between pharmacist prescriptive authority and increased COVID-19 vaccination rates is statistically significant. The results showed that allowing pharmacist to have prescriptive powers could potentially aid in reducing vaccine hesitancy for future pandemics.</p>","PeriodicalId":501014,"journal":{"name":"Innovations in pharmacy","volume":"16 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12509719/pdf/","citationCount":"0","resultStr":"{\"title\":\"The Effect of Expanded Pharmacist Prescriptive Authority on COVID-19 Vaccine Rates.\",\"authors\":\"Taylor Le, Thomas Kelly\",\"doi\":\"10.24926/iip.v16i1.6126\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><i>Background</i>: Recent legislatures have granted expanded prescriptive authority to pharmacists with a collaborative practice agreement with a physician. This authority could include prescribing tobacco cessation products, birth controls, and antivirals for COVID-19. Although closely associated with providing preventative measures for COVID-19 in the forms of testing and vaccinations, the relationship between pharmacist prescriptive power and rate of COVID-19 vaccination remains unexplored. The objective of the study is to determine the association between pharmacist prescriptive authority and the rate of COVID-19 vaccinations between neighboring counties along state lines of states with differing laws on this prescriptive power. <i>Methods</i>: States with expanded pharmacist prescriptive authority include: New Mexico, Oregon, Idaho, Florida, California, North Carolina, Montana, New York, Iowa, Massachusetts, and Ohio. Counties are selected if the center of the county is within 30 miles from a state border that divides a state with expanded pharmacist prescriptive authority from a state without. Monthly vaccination data from January 2021 to December 2021 was acquired from the Centers for Disease Control and Prevention and linear regression was performed and state-border-pair fixed effects was used as a control. <i>Results</i>: The estimated effect of expanded prescriptive authority is an increase of five percentage points in the share of the adult population that completed the initial COVID-19 vaccine series. <i>Conclusion</i>: The relationship between pharmacist prescriptive authority and increased COVID-19 vaccination rates is statistically significant. The results showed that allowing pharmacist to have prescriptive powers could potentially aid in reducing vaccine hesitancy for future pandemics.</p>\",\"PeriodicalId\":501014,\"journal\":{\"name\":\"Innovations in pharmacy\",\"volume\":\"16 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-04-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12509719/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Innovations in pharmacy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.24926/iip.v16i1.6126\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Innovations in pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24926/iip.v16i1.6126","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:最近的立法机构已经授予扩大处方权力药剂师与医生的合作实践协议。这一权力可能包括处方戒烟产品、节育和COVID-19抗病毒药物。尽管与以检测和疫苗接种的形式提供COVID-19预防措施密切相关,但药剂师处方权力与COVID-19疫苗接种率之间的关系仍未得到探索。该研究的目的是确定药剂师的规定权力与州界相邻县之间的COVID-19疫苗接种率之间的关系,这些州对这一规定权力有不同的法律。方法:扩大药师处方权限的州包括:新墨西哥州、俄勒冈州、爱达荷州、佛罗里达州、加利福尼亚州、北卡罗来纳州、蒙大拿州、纽约州、爱荷华州、马萨诸塞州和俄亥俄州。如果县中心距离州边界30英里以内,则选择具有扩大的药剂师规定权力的州和没有药剂师规定权力的州。从疾病控制和预防中心获得2021年1月至2021年12月的每月疫苗接种数据,并进行线性回归,并使用州-边界对固定效应作为对照。结果:扩大处方权限的估计效果是使完成初始COVID-19疫苗系列的成人人口比例增加5个百分点。结论:药师处方权威与COVID-19疫苗接种率的提高有统计学意义。结果表明,允许药剂师拥有处方权力可能有助于减少对未来流行病的疫苗犹豫。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

The Effect of Expanded Pharmacist Prescriptive Authority on COVID-19 Vaccine Rates.

The Effect of Expanded Pharmacist Prescriptive Authority on COVID-19 Vaccine Rates.

Background: Recent legislatures have granted expanded prescriptive authority to pharmacists with a collaborative practice agreement with a physician. This authority could include prescribing tobacco cessation products, birth controls, and antivirals for COVID-19. Although closely associated with providing preventative measures for COVID-19 in the forms of testing and vaccinations, the relationship between pharmacist prescriptive power and rate of COVID-19 vaccination remains unexplored. The objective of the study is to determine the association between pharmacist prescriptive authority and the rate of COVID-19 vaccinations between neighboring counties along state lines of states with differing laws on this prescriptive power. Methods: States with expanded pharmacist prescriptive authority include: New Mexico, Oregon, Idaho, Florida, California, North Carolina, Montana, New York, Iowa, Massachusetts, and Ohio. Counties are selected if the center of the county is within 30 miles from a state border that divides a state with expanded pharmacist prescriptive authority from a state without. Monthly vaccination data from January 2021 to December 2021 was acquired from the Centers for Disease Control and Prevention and linear regression was performed and state-border-pair fixed effects was used as a control. Results: The estimated effect of expanded prescriptive authority is an increase of five percentage points in the share of the adult population that completed the initial COVID-19 vaccine series. Conclusion: The relationship between pharmacist prescriptive authority and increased COVID-19 vaccination rates is statistically significant. The results showed that allowing pharmacist to have prescriptive powers could potentially aid in reducing vaccine hesitancy for future pandemics.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信